JP2003502270A5 - - Google Patents

Download PDF

Info

Publication number
JP2003502270A5
JP2003502270A5 JP2000512550A JP2000512550A JP2003502270A5 JP 2003502270 A5 JP2003502270 A5 JP 2003502270A5 JP 2000512550 A JP2000512550 A JP 2000512550A JP 2000512550 A JP2000512550 A JP 2000512550A JP 2003502270 A5 JP2003502270 A5 JP 2003502270A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
disease
hydroxy
formula
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000512550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003502270A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1998/006021 external-priority patent/WO1999015181A1/en
Publication of JP2003502270A publication Critical patent/JP2003502270A/ja
Publication of JP2003502270A5 publication Critical patent/JP2003502270A5/ja
Withdrawn legal-status Critical Current

Links

JP2000512550A 1998-09-22 1998-09-22 ２１−ヒドロキシ−６，１９−オキシドプロゲステロン（２１ｏｈ−６ｏｐ）、及びそれのグルココルチコイド過剰を治療する薬剤としての使用 Withdrawn JP2003502270A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1998/006021 WO1999015181A1 (en) 1997-09-23 1998-09-22 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids

Publications (2)

Publication Number Publication Date
JP2003502270A JP2003502270A (ja) 2003-01-21
JP2003502270A5 true JP2003502270A5 (de) 2006-01-05

Family

ID=8167069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000512550A Withdrawn JP2003502270A (ja) 1998-09-22 1998-09-22 ２１−ヒドロキシ−６，１９−オキシドプロゲステロン（２１ｏｈ−６ｏｐ）、及びそれのグルココルチコイド過剰を治療する薬剤としての使用

Country Status (1)

Country Link
JP (1) JP2003502270A (de)

Similar Documents

Publication Publication Date Title
JP2003503454A5 (de)
WO2002018327A3 (en) Guanidinobenzamides as mc4-r agonists
EP1283054A4 (de) Medikamente zur behandlung von komplikationen des diabetes und neuropathien, und verwendung davon
JP2003520232A5 (de)
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
JP2004517472A5 (de)
CA2274074A1 (en) Novel compounds with analgesic effect
WO2001076575A3 (en) The treatment of respiratory diseases
EE03951B1 (et) Inhaleeritav ravimvorm puistetihedusega 0,28 kuni0,38 g/ml, selle valmistamise protsess ja kasutamine
HUP0303524A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
CA2386690A1 (en) Pharmaceutical tramadol salts
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2001000566A3 (en) Substituted phenoxyacetic acids
JP2002522501A5 (de)
JP2001513504A5 (de)
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
ATE360428T1 (de) Analgetisches arzneimittel
AU2003290015A1 (en) Mastitis treatment
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
BE2016C017I2 (de)